General MedicationsORALGeneric
MIDOL
IBUPROFEN
Standard Dose
200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview MIDOL is listed in Drugs@FDA under application 071002 (ANDA).
Marketing status: Discontinued Active ingredient IBUPROFEN Form and strength CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BAYER Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview MIDOL is listed in Drugs@FDA under application 071002 (ANDA). Marketing status: Discontinued Active ingredient IBUPROFEN Form and strength CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BAYER Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.